307 related articles for article (PubMed ID: 8056190)
1. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Rossing P; Hommel E; Smidt UM; Parving HH
Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
[TBL] [Abstract][Full Text] [Related]
2. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Smidt UM
BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
[TBL] [Abstract][Full Text] [Related]
3. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing P; Hommel E; Smidt UM; Parving HH
Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
[TBL] [Abstract][Full Text] [Related]
4. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Parving HH; Rossing P; Hommel E; Smidt UM
Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
[TBL] [Abstract][Full Text] [Related]
6. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
[TBL] [Abstract][Full Text] [Related]
7. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Parving HH; Larsen M; Hommel E; Lund-Andersen H
Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
9. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
10. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
[TBL] [Abstract][Full Text] [Related]
11. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
Rossing P; Hommel E; Smidt UM; Parving HH
Diabetes; 1993 May; 42(5):715-9. PubMed ID: 8482428
[TBL] [Abstract][Full Text] [Related]
12. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
[TBL] [Abstract][Full Text] [Related]
13. High blood pressure is a major factor in progression of diabetic nephropathy.
Parving HH; Hommel E
J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ; Andersen S; Rossing P; Tarnow L; Parving HH
Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
[TBL] [Abstract][Full Text] [Related]
15. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
Parving HH; Andersen AR; Hommel E; Smidt U
Hypertension; 1985; 7(6 Pt 2):II114-7. PubMed ID: 4077229
[TBL] [Abstract][Full Text] [Related]
17. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
[TBL] [Abstract][Full Text] [Related]
18. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
Gall MA; Nielsen FS; Smidt UM; Parving HH
Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
[TBL] [Abstract][Full Text] [Related]
19. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
[TBL] [Abstract][Full Text] [Related]
20. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
